ALLEVYN◊ LIFE
Foam Dressings
It takes a great deal of innovation to be this simple.
In a climate of growing expectations and budget restrictions1,2, ALLEVYN LIFE Dressings have been shown to deliver improvements when added to pressure injury prevention protocols3-5 , and may help improve efficiency and patient satisfaction in community wound care6-12.
Absorbent hydrocellular foam dressing technology
Featuring a distinct five-layer, bordered design with a highly absorbent(1,12) core, ALLEVYN LIFE Dressings can absorb and lock away high levels of exudate (including viscous exudate)(1,5,12). Delivering long wear performance, they help to reduce the time and costs associated with dressing changes(1,2,13).
Featured Product
ALLEVYN™ Life Advanced Foam Wound Dressing
ALLEVYN LIFETM Dressings are available in multiple shapes and sizes, including options designed specifically to address the two sites at highest risk of developing pressure injuries – the sacrum and the heel(19).
Product Ordering Codes
| Code | Ergonomic Location | Length | Width |
|---|---|---|---|
General |
10.3cm |
10.3cm | |
General |
12.9cm |
12.9cm | |
General |
15.4cm |
15.4cm | |
General |
21cm |
21cm | |
Heel |
25.2cm |
25cm | |
Small Sacrum |
17.5cm |
17.2cm | |
Large Sacrum |
21.6cm |
21.6cm |
Resources
Gefen Data (2024) New MOA Evidence in Focus Pub Summary
Allevyn Gentle Border Lite Application Guide
Allevyn Gentle Border Application Sheet
Allevyn Life Heel Application Guide
Allevyn Life Quadrilobe Application Guide
Allevyn Life Single Sheet
Allevyn Life Sacrum Application Guide
*Compared to other foam dressings; p<0.001. As demonstrated in laboratory testing.
**except heel options.
***Compared with standard clinical practice.
1. Milne J, et al. J Wound Care. 2020;29(5):282-288.
2. Lindholm C, et al. Int Wound J. 2016;13 Suppl 2:5-15.
3. Smith+Nephew 2018. Internal report. DS/18/351/R.
4. Forni C, et al. Int Wound J. 2018; 15(3):383-390.
5. Forni C, et al. J Wound Care. 2020;29(2):120 – 127.
6. Joy H, et al. J Wound Care. 2015 Jul;24(7):312, 314-7.
7. Smith+Nephew 2018. Internal report. HVT080A 970A.
8. Simon D, et al. Wounds UK. 2014;10(3):80-87.
9. Rossington A, et al. Wounds UK. 2013;9(4):91-95.
10. Krönert GT, et al. EWMA Journal. 2016;16(2):7-12.
11. Stephen-Haynes J, et al. Journal of Community Nursing. 2013;27(5):50-59.
12. Tiscar-Gonzalez V, et al. Adv Skin Wound Care. 2021;34(1):23–30.
13. Stankiewicz M, et al. WP&R Journal. 2019;27(1):21 – 26
14. Moore Z, Forni C, Mcguiness W. Raising the Standards of care for reducing PU incidence and maintaining skin integrity. Paper presented at: EPUAP Symposium; 2017; Belfast, Northern Ireland.
15. Rossington A, Drysdale K, Winter R. Clinical performance and positive impact on patient wellbeing of ALLEVYN Life. Wounds UK. 2013;9(4):91 – 95
16. Fearns, N., Heller-Murphy, S., Kelly, J., Harbour, J. Placing the patient at the centre of chronic wound care: A qualitative evidence synthesis. Journal of Tissue Viability, Vol 26, Issue 4, Nov 2017 pp 254-259. https://doi.org/10.1016/j.jtv.2017.09.002
17. S+N Data on File. Wound Model Testing of New ALLEVYN Life Gen2 IM:I Dressing using Horse Serum at a Row Rate Modelling that of a Moderately Exuding Wound. DS/14/303/R. 2016.
18. S+N Data on File. Odour reducing properties of ALLEVYN LIFE. Internal Report. DS/12/127 /DOF. 2012
19. Bauer K, et al. Ostomy wound management. 2016;62(11):30-38.
20. Austin M. Paper presented at: SAWC; 2019.
21. Simon D, Biel A. A structured collaborative approach to appraise the clinical performance of a new product. Wounds UK. 2014;10(3):80-87
22. Smith & Nephew 2016. Product Performance of Next Generation ALLEVYN Life (HVT080). Internal Report. GMCA-DOF/08.
23. Smith & Nephew February 2016 2016. Subjective comparison of masking ability of the New ALLEVYN LIFE versus Current ALLEVYN LIFE by Healthcare Professionals. Internal Report. DS/16/061/R
24. Hurd T, Gregory L, Jones A, Brown S. A multi-centre in-market evaluation of ALLEVYN Gentle Border. Wounds UK. 2009;5(3):32-44.
25. Vowden K, Molemen N, Drysdale K, Mistry C. An open, prospective randomised, multi-centre clinical evaluation of a hydrocellular silicone foam dressing* in the management of exuding chronic and acute wounds. Paper presented at: EWMA; 2011; Brussels.
26. Matsumura H, Imai R, Ahmatjan N, et al. Removal of adhesive wound dressing and its effects on the stratum corneum of the skin: comparison of eight different adhesive wound dressings. Int Wound J. 2014;11(1):50-54.
27. Smith & Nephew May 2016 2016. New ALLEVYN Life Gen2 wcl – Physical Testing. Internal Report. DS/15/025/R.
28. Viamontes L, Jones, A.M., .Evaluation study of the properties of two adhesive foam dressings. British Journal of Nursing (Tissue Viability Supplement). 2003;12(11):S43-S49.
29. Smith & Nephew 2012. Simulated Wound Model Testing of ALLEVYN LIFE and Mepilex Border. Internal Report. DS/12/130/DOF.
30. Smith & Nephew, February 2016. New ALLEVYN LIFE Pad Perforation Size. Internal Report. DS/16/062/R.